GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS
- PMID: 30307448
- DOI: 10.24875/RIC.18002576
GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS
Abstract
Cardiovascular disease (CVD) is a broad definition for diseases of the heart and blood vessels with high mortality and morbidity worldwide. Atherosclerosis and hypertension are the most common causes of CVD, and multiple factors confer the susceptibility. Some of the predisposing factors are modifiable such as diet, smoking, and exercise, whereas others, including age, sex, and individual's genetic variations contributing to the CVD composition traits, are non-modifiable. This latter group includes serum lipid traits. High serum lipid levels, specifically high levels of serum low-density lipoprotein cholesterol and triglycerides, are well-established key risk factors of atherosclerosis. This review will discuss genomics and systems biology approaches in the study of common dyslipidemias. The non-Mendelian forms of dyslipidemias are highly complex, and the molecular mechanisms underlying these polygenic lipid disorders are estimated to involve hundreds of genes. Interactions between the different genes and environmental factors also contribute to the clinical outcomes; however, very little is known about these interactions and their molecular mechanisms. To better address the complex genetic architecture and multiple properties leading to high serum lipid levels, networks and systems approach combining information at genomic, transcriptomics, methylomics, proteomics, metabolomics, and phenome level are being developed, with the ultimate goal to elucidate the cascade of dynamic changes leading to CVD in humans. (REV INVEST CLIN. 2018;70:217-23).
Keywords: Allele specific expression; Cardiovascular disease; Coronary heart disease; Epigenomics; Genome-wide association study; High-density lipoprotein cholesterol; Low-density lipoprotein cholesterol; Metabolomics; Network; Personal medicine; Protein-protein interaction; Quantitative trait locus; Single nucleotide polymorphism; Systems genetics; Transcriptomics; Triglycerides; Type 2 diabetes; Weighted gene co-expression network analysis.
Copyright: © 2018 SecretarÍa de Salud.
Similar articles
-
Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.Angiology. 2007 Dec-2008 Jan;58(6):757-63. doi: 10.1177/0003319707304042. Angiology. 2007. PMID: 18216384
-
Lipid profile parameters in Malaysian dyslipidemic patients.Kobe J Med Sci. 2011 Dec 15;57(2):E38-48. Kobe J Med Sci. 2011. PMID: 22926072
-
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Curr Cardiol Rep. 2017 Jul;19(7):61. doi: 10.1007/s11886-017-0869-3. Curr Cardiol Rep. 2017. PMID: 28528455 Review.
-
Lipids and lipid management in diabetes.Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):325-38. doi: 10.1016/j.beem.2013.12.001. Epub 2013 Dec 18. Best Pract Res Clin Endocrinol Metab. 2014. PMID: 24840262 Review.
-
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.Can J Cardiol. 2017 Jul;33(7):872-882. doi: 10.1016/j.cjca.2016.12.019. Epub 2017 Jan 16. Can J Cardiol. 2017. PMID: 28365054 Review.
Cited by
-
Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis.J Cell Mol Med. 2020 Dec;24(23):13876-13898. doi: 10.1111/jcmm.15979. Epub 2020 Nov 2. J Cell Mol Med. 2020. PMID: 33140562 Free PMC article.
-
Neutrophil-Lymphocyte Ratio (NLR) for Predicting Clinical Outcomes in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus: A Propensity Score Matching Analysis.Ther Clin Risk Manag. 2020 May 19;16:437-443. doi: 10.2147/TCRM.S244623. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32547040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources